id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0137-0027,FDA,FDA-2009-D-0137,Guidance for Industry Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components Intended for Transfusion,Other,Guidance,2010-12-06T05:00:00Z,2010,12,2010-12-06T05:00:00Z,,2024-11-07T22:30:35Z,,1,0,0900006480bafc56
FDA-2009-D-0137-0025,FDA,FDA-2009-D-0137,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry; Use of Serological Tests to Reduce Risk of Transmission of Trypanosoma cruzi Infection, etc.",Notice,30 Day Proposed Information Collection,2010-12-06T05:00:00Z,2010,12,2010-12-06T05:00:00Z,2011-01-06T04:59:59Z,2016-10-28T18:34:06Z,2010-30404,0,0,0900006480bafe83
FDA-2009-D-0137-0026,FDA,FDA-2009-D-0137,"Guidance for Industry: Use of Serological Tests to Reduce Riskof Transmission of Trypanosoma cruzi Infection, etc.",Notice,Notice of Availability,2010-12-06T05:00:00Z,2010,12,2010-12-06T05:00:00Z,,2016-10-28T18:39:30Z,2010-30405,0,0,0900006480baff0b